Monday, October 5, 2026
CN
  • About
  • Advertise
  • Careers
  • Contact
Money Compass
  • Home
  • Financial News
  • Investment News
  • Other News
    • Bursa News
    • Government News
    • Listing Companies News
    • Oversea Financial & Investment News
  • Interviews
    • Features Interviews
    • Corporate Interviews
  • Financial & Investment Articles
  • PR Newswire
  • Login
No Result
View All Result
Money Compass
Home PR Newswire

Ajinomoto Bio-Pharma Services Unveils Refreshed Global Brand, Showcasing its Strength in Specialization

Money Compass by Money Compass
October 5, 2026
in PR Newswire
0
Ajinomoto Bio-Pharma Services Unveils Refreshed Global Brand, Showcasing its Strength in Specialization
1
SHARES
105
VIEWS
Share on FacebookShare on Twitter
  • Reflects the depth of expertise and innovation Aji Bio-Pharma brings to customers navigating increasingly demanding development and manufacturing challenges

TOKYO, Oct. 5, 2026 /PRNewswire/ — Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a global network of specialized contract development and manufacturing organizations (CDMOs) and enabling technologies, today unveiled a refreshed global brand including updated messaging and visual identity and a redeveloped global website that more clearly represents who the business is today and its commitment to supporting customers as they advance medicines that help improve the health of humankind.

Related posts

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.02 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $17.4 Billion

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.02 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $17.4 Billion

October 5, 2026
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.02 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $17.4 Billion

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.02 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $17.4 Billion

October 5, 2026

At a time when biopharma companies increasingly need depth of knowledge to navigate more demanding development and manufacturing challenges, Aji Bio-Pharma’s strength lies in specialization. Across small molecules, oligonucleotides, peptides, gene therapy, proteins, and bioconjugates, its business brings dedicated focus to distinct areas of biopharma, paired with the scientific innovation to solve the challenges within them.

Underpinning that specialization is Ajinomoto Group’s history of more than a century of scientific innovation. That legacy continues to shape Aji Bio-Pharma today, including the development of proprietary technologies that create new possibilities in biopharma development and manufacturing. Together with shared commitments to quality, operational excellence, and sustainability, this enables Aji Bio-Pharma to provide the reliability and partnership customers depend on as they advance their programs.

“Our team has always been driven to find new and better ways to solve the specific development and manufacturing challenges our customers face,” said Yasuyuki Otake, Corporate Executive, General Manager, Bio-Pharma Services Dept., Ajinomoto Co., Inc. “Our new brand puts that strength at the center. It reflects the ingenuity of our teams around the world and our commitment to helping customers unlock innovation and unleash the potential of their science for the patients they serve.”

The new brand launches today on Aji Bio-Pharma’s website, social media channels, and through updated global marketing materials at upcoming conferences, with additional assets transitioning to the new identity over the coming months.

About Ajinomoto Bio-Pharma Services
Ajinomoto Bio-Pharma Services is a global network of specialized contract development and manufacturing organizations (CDMOs) and enabling technologies with expertise across small molecules, oligonucleotides, peptides, gene therapy, proteins, and bioconjugates. With businesses and manufacturing sites in Belgium, India, Japan, and the U.S., we combine deep modality knowledge with Ajinomoto Group’s century-long legacy of scientific innovation and share a commitment to quality, operational excellence, and sustainability to help biopharma partners advance complex and novel medicines and help improve the health of humankind. Learn more at www.AjiBio-Pharma.com.

Media Inquiries
For media inquiries, please contact: HERE

Cision View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/ajinomoto-bio-pharma-services-unveils-refreshed-global-brand-showcasing-its-strength-in-specialization-302898327.html

SOURCE Ajinomoto Bio-Pharma Services

​ 

Previous Post

ARC Singapore launches with chapters set for four ASEAN markets

Next Post

Habitat for Humanity’s new global research report finds three in four people are cutting back on essentials to afford housing

Next Post
Habitat for Humanity’s new global research report finds three in four people are cutting back on essentials to afford housing

Habitat for Humanity's new global research report finds three in four people are cutting back on essentials to afford housing

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire

BROWSE BY TOPICS

2018 League Balinese Culture Bali United Budget Travel business Champions League Chopper Bike Doctor Terawan industrial Istana Negara Malaysia Market Stories National Exam net zero emissions targets 2025 Renewable energy Visit Bali

Recent News

  • Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.02 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $17.4 Billion
  • Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.02 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $17.4 Billion
  • MICROIP and AQLS Draw Defense, Healthcare and Energy Demand for NDAA-Compliant AI Drones at Taiwan Expo USA

Category

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire
  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Features Interviews
  • Government News
  • Financial News
  • Investment News
  • Listing Companies News
  • Corporate Interviews
  • Bursa News
  • Financial & Investment Articles
  • Oversea Financial & Investment News

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved